Komoto M, Tominaga K, Nakata B, Takashima T, Inoue T, Hirakawa K
Department of Surgery, Osaka Socio-Medical Center, Osaka, Japan.
J Exp Clin Cancer Res. 2006 Jun;25(2):283-5.
Recent studies have suggested that Helicobacter pylori (H. pylori)-associated gastritis may play an important role in the pathogenesis of primary gastric lymphoma. Recently, triple therapy using proton pump inhibitor, amoxicillin, and clarithromycin, has been established for the eradication therapy of H. pylori infection, and is also recommended for the treatment of the superficial type of low-grade gastric MALT (mucosa-associated lymphoid tissue ) lymphoma. MALT lymphoma of the gastric stump is rare, and total resection or chemotherapy for MALT lymphoma of the gastric stump has been previously reported. Therefore, there is no evidence that eradication therapy is effective for low-grade MALT lymphoma of the gastric stump. Our case illustrates the remarkable efficacy of eradication of H. pylori for low-grade MALT lymphoma of the gastric stump without other modalities such as surgery and systemic chemotherapy.
最近的研究表明,幽门螺杆菌(H. pylori)相关性胃炎可能在原发性胃淋巴瘤的发病机制中起重要作用。最近,已确立使用质子泵抑制剂、阿莫西林和克拉霉素的三联疗法用于根除幽门螺杆菌感染的治疗,并且也推荐用于治疗浅表型低级别胃黏膜相关淋巴组织(MALT)淋巴瘤。胃残端MALT淋巴瘤罕见,先前已有关于胃残端MALT淋巴瘤全切除或化疗的报道。因此,尚无证据表明根除疗法对胃残端低级别MALT淋巴瘤有效。我们的病例表明,对于胃残端低级别MALT淋巴瘤,在不采用手术和全身化疗等其他方式的情况下,根除幽门螺杆菌具有显著疗效。